Thursday, May 1, 1997
South San Francisco, Calif. -- May 1, 1997 --Genentech, Inc. (NYSE: GNE) today announced the appointment of Lars Barfod as Vice President of Marketing. Barfod will report directly to David Roche, Senior Vice President of Sales and Marketing at Genentech. Barfod previously served as Vice President of Marketing and Business Development at Novo Nordisk Pharmaceuticals, Inc., where he also served as acting Vice President of Sales.
Prior to Novo Nordisk, Barfod served in various capacities in product management and science at Hansens' Laboratories in Denmark. Barfod holds his master's of science degree in marketing with a concentration in microbiology and biochemistry from Copenhagen Royal University.
Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures, and markets human pharmaceuticals for significant unmet medical needs. Eleven of the currently marketed biotechnology products stem from Genentech science, six of which Genentech markets directly in the United States. The company has headquarters in South San Francisco, California, and is traded on the New York Stock Exchange and Pacific Exchange under the symbol GNE.
# # #